Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

81 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
A cross-sectional study of the prevalence of cardiac valvular abnormalities in hyperprolactinemic patients treated with ergot-derived dopamine agonists.
Drake WM, Stiles CE, Howlett TA, Toogood AA, Bevan JS, Steeds RP; UK Dopamine Agonist Valvulopathy Group. Drake WM, et al. Among authors: toogood aa. J Clin Endocrinol Metab. 2014 Jan;99(1):90-6. doi: 10.1210/jc.2013-2254. Epub 2013 Dec 20. J Clin Endocrinol Metab. 2014. PMID: 24187407 Free PMC article.
Dopamine agonist therapy and cardiac valve dysfunction.
Sherlock M, Steeds R, Toogood AA. Sherlock M, et al. Among authors: toogood aa. Clin Endocrinol (Oxf). 2007 Nov;67(5):643-4. doi: 10.1111/j.1365-2265.2007.02974.x. Epub 2007 Jul 20. Clin Endocrinol (Oxf). 2007. PMID: 17645575 No abstract available.
Mortality in patients with pituitary disease.
Sherlock M, Ayuk J, Tomlinson JW, Toogood AA, Aragon-Alonso A, Sheppard MC, Bates AS, Stewart PM. Sherlock M, et al. Among authors: toogood aa. Endocr Rev. 2010 Jun;31(3):301-42. doi: 10.1210/er.2009-0033. Epub 2010 Jan 19. Endocr Rev. 2010. PMID: 20086217 Review.
Extensive experience in the management of macroprolactinomas.
Green AI, Sherlock M, Stewart PM, Gittoes NJ, Toogood AA. Green AI, et al. Among authors: toogood aa. Clin Endocrinol (Oxf). 2014 Jul;81(1):85-92. doi: 10.1111/cen.12418. Epub 2014 Mar 13. Clin Endocrinol (Oxf). 2014. PMID: 24483350
The modulation of corticosteroid metabolism by hydrocortisone therapy in patients with hypopituitarism increases tissue glucocorticoid exposure.
Sherlock M, Behan LA, Hannon MJ, Alonso AA, Thompson CJ, Murray RD, Crabtree N, Hughes BA, Arlt W, Agha A, Toogood AA, Stewart PM. Sherlock M, et al. Among authors: toogood aa. Eur J Endocrinol. 2015 Nov;173(5):583-93. doi: 10.1530/EJE-15-0490. Epub 2015 Aug 11. Eur J Endocrinol. 2015. PMID: 26264718 Clinical Trial.
A Follow-Up Study of the Prevalence of Valvular Heart Abnormalities in Hyperprolactinemic Patients Treated With Cabergoline.
Drake WM, Stiles CE, Bevan JS, Karavitaki N, Trainer PJ, Rees DA, Richardson TI, Baldeweg SE, Stojanovic N, Murray RD, Toogood AA, Martin NM, Vaidya B, Han TS, Steeds RP; UK Cabergoline valvulopathy study group; Baldeweg FC, Sheikh UE, Kyriakakis N, Parasuraman SK, Taylor L, Butt N, Anyiam S. Drake WM, et al. Among authors: toogood aa. J Clin Endocrinol Metab. 2016 Nov;101(11):4189-4194. doi: 10.1210/jc.2016-2224. Epub 2016 Aug 29. J Clin Endocrinol Metab. 2016. PMID: 27571182
81 results